These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16046222)

  • 21. Usefulness of triglycerides-to-high-density lipoprotein cholesterol ratio for predicting the first coronary event in men.
    Cordero A; Andrés E; Ordoñez B; León M; Laclaustra M; Grima A; Luengo E; Moreno J; Bes M; Pascual I; Civeira F; Pocoví M; Alegría E; Casasnovas JA;
    Am J Cardiol; 2009 Nov; 104(10):1393-7. PubMed ID: 19892056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adiponectin and coronary heart disease: a prospective study and meta-analysis.
    Sattar N; Wannamethee G; Sarwar N; Tchernova J; Cherry L; Wallace AM; Danesh J; Whincup PH
    Circulation; 2006 Aug; 114(7):623-9. PubMed ID: 16894037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cystatin C: a promising marker and predictor of impaired renal function.
    Westhuyzen J
    Ann Clin Lab Sci; 2006; 36(4):387-94. PubMed ID: 17127725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6.
    Hulthe J; McPheat W; Samnegård A; Tornvall P; Hamsten A; Eriksson P
    Atherosclerosis; 2006 Oct; 188(2):450-4. PubMed ID: 16405895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines.
    Shai I; Rimm EB; Hankinson SE; Curhan G; Manson JE; Rifai N; Stampfer MJ; Ma J
    Circulation; 2004 Nov; 110(18):2824-30. PubMed ID: 15492318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Is there a relationship between cystatin C and inflammatory status, oxidative stress and other cardiovascular risk factors in non-diabetic patients with chronic kidney disease?].
    Font R; Prats M; Gutiérrez C; Bardají A; Lalana M; Marsillach J; Camps J; Martínez Vea A
    Nefrologia; 2009; 29(3):228-35. PubMed ID: 19554056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystatin C--a marker of peripheral atherosclerotic disease?
    Arpegård J; Ostergren J; de Faire U; Hansson LO; Svensson P
    Atherosclerosis; 2008 Aug; 199(2):397-401. PubMed ID: 18187137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study.
    Luc G; Arveiler D; Evans A; Amouyel P; Ferrieres J; Bard JM; Elkhalil L; Fruchart JC; Ducimetiere P;
    Atherosclerosis; 2003 Sep; 170(1):169-76. PubMed ID: 12957696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum cystatin C and increased coronary heart disease prevalence in US adults without chronic kidney disease.
    Muntner P; Mann D; Winston J; Bansilal S; Farkouh ME
    Am J Cardiol; 2008 Jul; 102(1):54-7. PubMed ID: 18572035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory and anti-inflammatory variable clusters and risk prediction in acute coronary syndrome patients: a factor analysis approach.
    Tziakas DN; Chalikias GK; Kaski JC; Kekes A; Hatzinikolaou EI; Stakos DA; Tentes IK; Kortsaris AX; Hatseras DI
    Atherosclerosis; 2007 Jul; 193(1):196-203. PubMed ID: 16857204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased serum cystatin C is associated with increased mortality in elderly men.
    Larsson A; Helmersson J; Hansson LO; Basu S
    Scand J Clin Lab Invest; 2005; 65(4):301-5. PubMed ID: 16076685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cystatin C as a Marker of Progressing Cardiovascular Events during Coronary Heart Disease.
    Gevorgyan MM; Voronina NP; Goncharova NV; Kozaruk TV; Russkikh GS; Bogdanova LA; Korolenko TA
    Bull Exp Biol Med; 2017 Feb; 162(4):421-424. PubMed ID: 28239794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum cystatin C and the risk of Alzheimer disease in elderly men.
    Sundelöf J; Arnlöv J; Ingelsson E; Sundström J; Basu S; Zethelius B; Larsson A; Irizarry MC; Giedraitis V; Rönnemaa E; Degerman-Gunnarsson M; Hyman BT; Basun H; Kilander L; Lannfelt L
    Neurology; 2008 Sep; 71(14):1072-9. PubMed ID: 18824671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased serum cathepsin S in patients with atherosclerosis and diabetes.
    Liu J; Ma L; Yang J; Ren A; Sun Z; Yan G; Sun J; Fu H; Xu W; Hu C; Shi GP
    Atherosclerosis; 2006 Jun; 186(2):411-9. PubMed ID: 16140306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate.
    Niccoli G; Conte M; Della Bona R; Altamura L; Siviglia M; Dato I; Ferrante G; Leone AM; Porto I; Burzotta F; Brugaletta S; Biasucci LM; Crea F
    Atherosclerosis; 2008 Jun; 198(2):373-80. PubMed ID: 17983622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homocysteine and endogenous markers of renal function in type 2 diabetic patients without coronary heart disease.
    Abdella N; Mojiminiyi OA; Akanji AO
    Diabetes Res Clin Pract; 2000 Dec; 50(3):177-85. PubMed ID: 11106832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients.
    Cimerman N; Brguljan PM; Krasovec M; Suskovic S; Kos J
    Clin Chim Acta; 2000 Oct; 300(1-2):83-95. PubMed ID: 10958865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between plasma fibrinogen and coronary heart disease in women.
    Eriksson M; Egberg N; Wamala S; Orth-Gomér K; Mittleman MA; Schenck-Gustafsson K
    Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):67-72. PubMed ID: 9888868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.